CARLOS CABALLERO: Open Payments
NPI 1679939185 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 29 payments from 13 companies in 2025. Trend: 2023 $442 · 2024 $312 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation | 1 | $153 |
| ABBVIE INC. | 5 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Astellas Pharma US Inc | 5 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Boston Scientific Corporation | 1 | $28 |
| Endo USA, Inc. | 1 | $28 |
| Ethicon US, LLC | 1 | $25 |
Products named: AQUABEAM ROBOTIC SYSTEM, Nubeqa, BOTOX, Xtandi, PLUVICTO, LUPRON DEPOT, ORGOVYX, AMS 700.
Industry payments across FL — which companies pay providers there.
